Royal Bank of Canada’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.96M Buy
172,479
+145,743
+545% +$4.19M ﹤0.01% 2345
2025
Q1
$897K Sell
26,736
-2,544
-9% -$85.4K ﹤0.01% 3248
2024
Q4
$1.5M Sell
29,280
-5,803
-17% -$297K ﹤0.01% 2842
2024
Q3
$1.79M Buy
35,083
+3,417
+11% +$175K ﹤0.01% 2723
2024
Q2
$1.42M Buy
31,666
+6,641
+27% +$297K ﹤0.01% 2858
2024
Q1
$1.17M Buy
25,025
+4,010
+19% +$188K ﹤0.01% 2964
2023
Q4
$749K Buy
21,015
+10,211
+95% +$364K ﹤0.01% 3414
2023
Q3
$321K Buy
10,804
+5,209
+93% +$155K ﹤0.01% 3923
2023
Q2
$100K Buy
5,595
+2,201
+65% +$39.3K ﹤0.01% 4900
2023
Q1
$54K Sell
3,394
-3,496
-51% -$55.6K ﹤0.01% 5197
2022
Q4
$126K Buy
6,890
+5,883
+584% +$108K ﹤0.01% 4816
2022
Q3
$20K Buy
1,007
+345
+52% +$6.85K ﹤0.01% 5641
2022
Q2
$13K Sell
662
-2,426
-79% -$47.6K ﹤0.01% 5801
2022
Q1
$68K Sell
3,088
-6,735
-69% -$148K ﹤0.01% 5403
2021
Q4
$279K Buy
9,823
+6,546
+200% +$186K ﹤0.01% 4499
2021
Q3
$69K Buy
3,277
+380
+13% +$8K ﹤0.01% 5449
2021
Q2
$55K Buy
2,897
+1,111
+62% +$21.1K ﹤0.01% 5479
2021
Q1
$27K Buy
1,786
+1,219
+215% +$18.4K ﹤0.01% 5747
2020
Q4
$8K Buy
567
+530
+1,432% +$7.48K ﹤0.01% 5914
2020
Q3
$1K Sell
37
-686
-95% -$18.5K ﹤0.01% 5908
2020
Q2
$12K Buy
723
+447
+162% +$7.42K ﹤0.01% 5290
2020
Q1
$4K Sell
276
-206
-43% -$2.99K ﹤0.01% 5599
2019
Q4
$12K Buy
482
+67
+16% +$1.67K ﹤0.01% 5465
2019
Q3
$6K Hold
415
﹤0.01% 5308
2019
Q2
$10K Hold
415
﹤0.01% 5174
2019
Q1
$9K Buy
415
+385
+1,283% +$8.35K ﹤0.01% 5139
2018
Q4
$1K Sell
30
-298
-91% -$9.93K ﹤0.01% 5639
2018
Q3
$9K Buy
+328
New +$9K ﹤0.01% 5411